Table 1. Studies contributing to evaluation of associations between rs1607237 and breast cancer risk.
| Study a | Country | Cases n (%) | Controls n (%) |
|---|---|---|---|
| ABCFS | Australia | 1199 (3.1) | 438 (1.2) |
| ABCS | The Netherlands | 1465 (3.8) | 548 (1.5) |
| BBCC | Germany | 1060 (2.8) | 994 (2.7) |
| BBCS | UK | 1153 (3.0) | 831 (2.3) |
| BIGGS | Ireland | 1060 (2.8) | 900 (2.5) |
| CGEMSb | USA | 5436 (14.2) | 5280 (14.4) |
| CNIO-BCS | Spain | 752 (2.0) | 823 (2.2) |
| GC-HBOC | Germany | 864 (2.3) | 1224 (3.3) |
| GENICA | Germany | 1013 (2.7) | 1012 (2.8) |
| GESBC | Germany | 563 (1.5) | 564 (1.5) |
| HABCS | Germany | 1046 (2.7) | 998 (2.7) |
| HMBCS | Belarus | 1760 (4.6) | 1015 (2.8) |
| KARBAC | Sweden | 812 (2.1) | 863 (2.4) |
| kConFab/AOCS | Australia/New Zealand | 566 (1.5) | 899 (2.5) |
| KBCP | Finland | 485 (1.3) | 427 (1.2) |
| MARIE | Germany | 2754 (7.2) | 5302 (14.5) |
| MBCSG | Italy | 739 (1.9) | 1231 (3.4) |
| MCBCSc | USA | 1789 (4.7) | 1554 (4.2) |
| MCCS | Australia | 679 (1.8) | 751 (2.1) |
| NC-BCFR | USA | 388 (1.0) | 154 (0.4) |
| OBCS | Finland | 544 (1.4) | 509 (1.4) |
| OFBCR | Canada | 1170 (3.1) | 329 (0.9) |
| SBCS | UK | 1217 (3.2) | 1201 (3.3) |
| SEARCH | UK | 6520 (17.1) | 6779 (18.5) |
| SEBCSd | Korea | 1732 (4.5) | 1178 (3.2) |
| TBCSd | Thailand | 451 (1.2) | 291 (0.8) |
| UCIBCS | USA | 957 (2.5) | 527 (1.4) |
| Total | 38 174 (100) | 36 622 (100) |
a
See Supplementary Table 1 for definition of study acronyms.
b
Stage 2: Cancer Genetic Markers of Susceptibility study.
c
Includes Stage 1: Mayo Clinic Breast Cancer Study.
d
Asian case–control studies.